Investigating pharmaceutical marketing in Canada using American prosecutions
نویسندگان
چکیده
منابع مشابه
Investigating pharmaceutical marketing in Canada using American prosecutions.
BACKGROUND Pharmaceutical companies are prohibited from marketing medications for off-label uses in both the United States and Canada. In the United States, there have been several recent multi-billion dollar settlements with pharmaceutical companies based, partly, on off-label promotion. Health Canada has not publicized any investigations into, or prosecutions of, pharmaceutical companies for ...
متن کاملUsing Predictive Analysis to Optimize Pharmaceutical Marketing
Most businesses have benefited from utilizing advanced analytics for marketing and other decision making. However, to apply analytical techniques for pharmaceutical marketing is challenging and emerging as it is critical to ensure the analysis makes sense from the medical side. Whether the drug for a specific disease finally consumed is directly and indirectly influenced by many factors includi...
متن کاملPharmaceutical Marketing – Time for Change
This paper reviews current marketing practices in the pharmaceutical sector, and their impact on consumer and doctor behaviour. It identifies negative impacts which include misleading advertising, disease mongering and escalating costs. It argues the need to move from industry self-regulation to an independently monitored code of practice for pharmaceutical marketing.
متن کاملRecognizing misleading pharmaceutical marketing online.
In light of decision-making psychology, this article details how drug marketing operates across established and novel web domains and identifies some common misleading trends and influences on prescribing and patient-initiated medication requests. The Internet has allowed pharmaceutical marketing to become more salient than ever before. Although the Internet's growth has improved the disseminat...
متن کاملA New Pharmaceutical Environment in Iran: Marketing Impacts
For nearly 25 years, Iranian Pharmaceutical market has been a closed and centrally controlled one. Although some initiatives have been introduced during the last decade, yet the system is characterized as a closed one and lacks real competition. The current situation of drug in Iran may be characterized as: Intense price control by the Drug Authority i.e. Ministry of Health Ban of d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Risk & Safety in Medicine
سال: 2014
ISSN: 0924-6479
DOI: 10.3233/jrs-140619